 | • レポートコード：GIR-23F3830 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Hyaluronic Acid (HA) for Medical Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の医療用ヒアルロン酸（HA）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 医療用ヒアルロン酸（HA）市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・注射、パッチ アプリケーション別セグメントは次のように区分されます。 ・医療衛生、形成外科、健康製品、その他 世界の医療用ヒアルロン酸（HA）市場の主要なマーケットプレーヤーは以下のとおりです。 ・Kewpie、CPN、Shiseido、Novozymes、Bloomage BioTechnology、Shandong Galaxy Bio-Tech、China Eastar、FocusChem Biotech、Shandong Topscience Biotech、QuFu GuangLong Biochem、Weifang Lide Bioengineering、Jiangsu Haihua Biotech、Qufu Liyang Biochem Industrial、HAOHAI BIO-MED 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 医療用ヒアルロン酸（HA）の概要 - タイプ別分析（2017年vs2021年vs2028年）：注射、パッチ - アプリケーション別分析（2017年vs2021年vs2028年）：医療衛生、形成外科、健康製品、その他 - 世界の医療用ヒアルロン酸（HA）市場規模・予測 - 世界の医療用ヒアルロン酸（HA）生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Kewpie、CPN、Shiseido、Novozymes、Bloomage BioTechnology、Shandong Galaxy Bio-Tech、China Eastar、FocusChem Biotech、Shandong Topscience Biotech、QuFu GuangLong Biochem、Weifang Lide Bioengineering、Jiangsu Haihua Biotech、Qufu Liyang Biochem Industrial、HAOHAI BIO-MED ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：注射、パッチ ・アプリケーション別分析2017年-2028年：医療衛生、形成外科、健康製品、その他 ・医療用ヒアルロン酸（HA）の北米市場分析 - 医療用ヒアルロン酸（HA）の北米市場：タイプ別市場規模2017年-2028年 - 医療用ヒアルロン酸（HA）の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・医療用ヒアルロン酸（HA）のヨーロッパ市場分析 - ：医療用ヒアルロン酸（HA）のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：医療用ヒアルロン酸（HA）のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・医療用ヒアルロン酸（HA）のアジア太平洋市場分析 - 医療用ヒアルロン酸（HA）のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 医療用ヒアルロン酸（HA）のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・医療用ヒアルロン酸（HA）の南米市場分析 - 医療用ヒアルロン酸（HA）の南米市場：タイプ別市場規模2017年-2028年 - 医療用ヒアルロン酸（HA）の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・医療用ヒアルロン酸（HA）の中東・アフリカ市場分析 - 医療用ヒアルロン酸（HA）の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 医療用ヒアルロン酸（HA）の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hyaluronic Acid (HA) for Medical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hyaluronic Acid (HA) for Medical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Medical Hygiene accounting for % of the Hyaluronic Acid (HA) for Medical global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hyaluronic Acid (HA) for Medical include Kewpie, CPN, Shiseido, Novozymes, and Bloomage BioTechnology, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hyaluronic Acid (HA) for Medical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Patch
Market segment by Application can be divided into
Medical Hygiene
Plastic Surgery
Health Products
Other
The key market players for global Hyaluronic Acid (HA) for Medical market are listed below:
Kewpie
CPN
Shiseido
Novozymes
Bloomage BioTechnology
Shandong Galaxy Bio-Tech
China Eastar
FocusChem Biotech
Shandong Topscience Biotech
QuFu GuangLong Biochem
Weifang Lide Bioengineering
Jiangsu Haihua Biotech
Qufu Liyang Biochem Industrial
HAOHAI BIO-MED
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyaluronic Acid (HA) for Medical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hyaluronic Acid (HA) for Medical, with price, sales, revenue and global market share of Hyaluronic Acid (HA) for Medical from 2019 to 2022.
Chapter 3, the Hyaluronic Acid (HA) for Medical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyaluronic Acid (HA) for Medical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hyaluronic Acid (HA) for Medical market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hyaluronic Acid (HA) for Medical.
Chapter 13, 14, and 15, to describe Hyaluronic Acid (HA) for Medical sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Hyaluronic Acid (HA) for Medical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hyaluronic Acid (HA) for Medical Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Injection
1.2.3 Patch
1.3 Market Analysis by Application
1.3.1 Overview: Global Hyaluronic Acid (HA) for Medical Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Medical Hygiene
1.3.3 Plastic Surgery
1.3.4 Health Products
1.3.5 Other
1.4 Global Hyaluronic Acid (HA) for Medical Market Size & Forecast
1.4.1 Global Hyaluronic Acid (HA) for Medical Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hyaluronic Acid (HA) for Medical Sales in Volume (2017-2028)
1.4.3 Global Hyaluronic Acid (HA) for Medical Price (2017-2028)
1.5 Global Hyaluronic Acid (HA) for Medical Production Capacity Analysis
1.5.1 Global Hyaluronic Acid (HA) for Medical Total Production Capacity (2017-2028)
1.5.2 Global Hyaluronic Acid (HA) for Medical Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hyaluronic Acid (HA) for Medical Market Drivers
1.6.2 Hyaluronic Acid (HA) for Medical Market Restraints
1.6.3 Hyaluronic Acid (HA) for Medical Trends Analysis
2 Manufacturers Profiles
2.1 Kewpie
2.1.1 Kewpie Details
2.1.2 Kewpie Major Business
2.1.3 Kewpie Hyaluronic Acid (HA) for Medical Product and Services
2.1.4 Kewpie Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CPN
2.2.1 CPN Details
2.2.2 CPN Major Business
2.2.3 CPN Hyaluronic Acid (HA) for Medical Product and Services
2.2.4 CPN Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Shiseido
2.3.1 Shiseido Details
2.3.2 Shiseido Major Business
2.3.3 Shiseido Hyaluronic Acid (HA) for Medical Product and Services
2.3.4 Shiseido Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novozymes
2.4.1 Novozymes Details
2.4.2 Novozymes Major Business
2.4.3 Novozymes Hyaluronic Acid (HA) for Medical Product and Services
2.4.4 Novozymes Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bloomage BioTechnology
2.5.1 Bloomage BioTechnology Details
2.5.2 Bloomage BioTechnology Major Business
2.5.3 Bloomage BioTechnology Hyaluronic Acid (HA) for Medical Product and Services
2.5.4 Bloomage BioTechnology Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Shandong Galaxy Bio-Tech
2.6.1 Shandong Galaxy Bio-Tech Details
2.6.2 Shandong Galaxy Bio-Tech Major Business
2.6.3 Shandong Galaxy Bio-Tech Hyaluronic Acid (HA) for Medical Product and Services
2.6.4 Shandong Galaxy Bio-Tech Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 China Eastar
2.7.1 China Eastar Details
2.7.2 China Eastar Major Business
2.7.3 China Eastar Hyaluronic Acid (HA) for Medical Product and Services
2.7.4 China Eastar Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 FocusChem Biotech
2.8.1 FocusChem Biotech Details
2.8.2 FocusChem Biotech Major Business
2.8.3 FocusChem Biotech Hyaluronic Acid (HA) for Medical Product and Services
2.8.4 FocusChem Biotech Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shandong Topscience Biotech
2.9.1 Shandong Topscience Biotech Details
2.9.2 Shandong Topscience Biotech Major Business
2.9.3 Shandong Topscience Biotech Hyaluronic Acid (HA) for Medical Product and Services
2.9.4 Shandong Topscience Biotech Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 QuFu GuangLong Biochem
2.10.1 QuFu GuangLong Biochem Details
2.10.2 QuFu GuangLong Biochem Major Business
2.10.3 QuFu GuangLong Biochem Hyaluronic Acid (HA) for Medical Product and Services
2.10.4 QuFu GuangLong Biochem Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Weifang Lide Bioengineering
2.11.1 Weifang Lide Bioengineering Details
2.11.2 Weifang Lide Bioengineering Major Business
2.11.3 Weifang Lide Bioengineering Hyaluronic Acid (HA) for Medical Product and Services
2.11.4 Weifang Lide Bioengineering Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Jiangsu Haihua Biotech
2.12.1 Jiangsu Haihua Biotech Details
2.12.2 Jiangsu Haihua Biotech Major Business
2.12.3 Jiangsu Haihua Biotech Hyaluronic Acid (HA) for Medical Product and Services
2.12.4 Jiangsu Haihua Biotech Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Qufu Liyang Biochem Industrial
2.13.1 Qufu Liyang Biochem Industrial Details
2.13.2 Qufu Liyang Biochem Industrial Major Business
2.13.3 Qufu Liyang Biochem Industrial Hyaluronic Acid (HA) for Medical Product and Services
2.13.4 Qufu Liyang Biochem Industrial Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 HAOHAI BIO-MED
2.14.1 HAOHAI BIO-MED Details
2.14.2 HAOHAI BIO-MED Major Business
2.14.3 HAOHAI BIO-MED Hyaluronic Acid (HA) for Medical Product and Services
2.14.4 HAOHAI BIO-MED Hyaluronic Acid (HA) for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hyaluronic Acid (HA) for Medical Breakdown Data by Manufacturer
3.1 Global Hyaluronic Acid (HA) for Medical Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hyaluronic Acid (HA) for Medical Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hyaluronic Acid (HA) for Medical
3.4 Market Concentration Rate
3.4.1 Top 3 Hyaluronic Acid (HA) for Medical Manufacturer Market Share in 2021
3.4.2 Top 6 Hyaluronic Acid (HA) for Medical Manufacturer Market Share in 2021
3.5 Global Hyaluronic Acid (HA) for Medical Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hyaluronic Acid (HA) for Medical Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hyaluronic Acid (HA) for Medical Market Size by Region
4.1.1 Global Hyaluronic Acid (HA) for Medical Sales in Volume by Region (2017-2028)
4.1.2 Global Hyaluronic Acid (HA) for Medical Revenue by Region (2017-2028)
4.2 North America Hyaluronic Acid (HA) for Medical Revenue (2017-2028)
4.3 Europe Hyaluronic Acid (HA) for Medical Revenue (2017-2028)
4.4 Asia-Pacific Hyaluronic Acid (HA) for Medical Revenue (2017-2028)
4.5 South America Hyaluronic Acid (HA) for Medical Revenue (2017-2028)
4.6 Middle East and Africa Hyaluronic Acid (HA) for Medical Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hyaluronic Acid (HA) for Medical Sales in Volume by Type (2017-2028)
5.2 Global Hyaluronic Acid (HA) for Medical Revenue by Type (2017-2028)
5.3 Global Hyaluronic Acid (HA) for Medical Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hyaluronic Acid (HA) for Medical Sales in Volume by Application (2017-2028)
6.2 Global Hyaluronic Acid (HA) for Medical Revenue by Application (2017-2028)
6.3 Global Hyaluronic Acid (HA) for Medical Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hyaluronic Acid (HA) for Medical Sales by Type (2017-2028)
7.2 North America Hyaluronic Acid (HA) for Medical Sales by Application (2017-2028)
7.3 North America Hyaluronic Acid (HA) for Medical Market Size by Country
7.3.1 North America Hyaluronic Acid (HA) for Medical Sales in Volume by Country (2017-2028)
7.3.2 North America Hyaluronic Acid (HA) for Medical Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hyaluronic Acid (HA) for Medical Sales by Type (2017-2028)
8.2 Europe Hyaluronic Acid (HA) for Medical Sales by Application (2017-2028)
8.3 Europe Hyaluronic Acid (HA) for Medical Market Size by Country
8.3.1 Europe Hyaluronic Acid (HA) for Medical Sales in Volume by Country (2017-2028)
8.3.2 Europe Hyaluronic Acid (HA) for Medical Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hyaluronic Acid (HA) for Medical Sales by Type (2017-2028)
9.2 Asia-Pacific Hyaluronic Acid (HA) for Medical Sales by Application (2017-2028)
9.3 Asia-Pacific Hyaluronic Acid (HA) for Medical Market Size by Region
9.3.1 Asia-Pacific Hyaluronic Acid (HA) for Medical Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hyaluronic Acid (HA) for Medical Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hyaluronic Acid (HA) for Medical Sales by Type (2017-2028)
10.2 South America Hyaluronic Acid (HA) for Medical Sales by Application (2017-2028)
10.3 South America Hyaluronic Acid (HA) for Medical Market Size by Country
10.3.1 South America Hyaluronic Acid (HA) for Medical Sales in Volume by Country (2017-2028)
10.3.2 South America Hyaluronic Acid (HA) for Medical Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hyaluronic Acid (HA) for Medical Sales by Type (2017-2028)
11.2 Middle East & Africa Hyaluronic Acid (HA) for Medical Sales by Application (2017-2028)
11.3 Middle East & Africa Hyaluronic Acid (HA) for Medical Market Size by Country
11.3.1 Middle East & Africa Hyaluronic Acid (HA) for Medical Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hyaluronic Acid (HA) for Medical Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hyaluronic Acid (HA) for Medical and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hyaluronic Acid (HA) for Medical
12.3 Hyaluronic Acid (HA) for Medical Production Process
12.4 Hyaluronic Acid (HA) for Medical Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hyaluronic Acid (HA) for Medical Typical Distributors
13.3 Hyaluronic Acid (HA) for Medical Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Hyaluronic Acid (HA) for Medical Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Hyaluronic Acid (HA) for Medical Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Kewpie Basic Information, Manufacturing Base and Competitors
Table 4. Kewpie Major Business
Table 5. Kewpie Hyaluronic Acid (HA) for Medical Product and Services
Table 6. Kewpie Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CPN Basic Information, Manufacturing Base and Competitors
Table 8. CPN Major Business
Table 9. CPN Hyaluronic Acid (HA) for Medical Product and Services
Table 10. CPN Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Shiseido Basic Information, Manufacturing Base and Competitors
Table 12. Shiseido Major Business
Table 13. Shiseido Hyaluronic Acid (HA) for Medical Product and Services
Table 14. Shiseido Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novozymes Basic Information, Manufacturing Base and Competitors
Table 16. Novozymes Major Business
Table 17. Novozymes Hyaluronic Acid (HA) for Medical Product and Services
Table 18. Novozymes Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bloomage BioTechnology Basic Information, Manufacturing Base and Competitors
Table 20. Bloomage BioTechnology Major Business
Table 21. Bloomage BioTechnology Hyaluronic Acid (HA) for Medical Product and Services
Table 22. Bloomage BioTechnology Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Shandong Galaxy Bio-Tech Basic Information, Manufacturing Base and Competitors
Table 24. Shandong Galaxy Bio-Tech Major Business
Table 25. Shandong Galaxy Bio-Tech Hyaluronic Acid (HA) for Medical Product and Services
Table 26. Shandong Galaxy Bio-Tech Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. China Eastar Basic Information, Manufacturing Base and Competitors
Table 28. China Eastar Major Business
Table 29. China Eastar Hyaluronic Acid (HA) for Medical Product and Services
Table 30. China Eastar Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. FocusChem Biotech Basic Information, Manufacturing Base and Competitors
Table 32. FocusChem Biotech Major Business
Table 33. FocusChem Biotech Hyaluronic Acid (HA) for Medical Product and Services
Table 34. FocusChem Biotech Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Shandong Topscience Biotech Basic Information, Manufacturing Base and Competitors
Table 36. Shandong Topscience Biotech Major Business
Table 37. Shandong Topscience Biotech Hyaluronic Acid (HA) for Medical Product and Services
Table 38. Shandong Topscience Biotech Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. QuFu GuangLong Biochem Basic Information, Manufacturing Base and Competitors
Table 40. QuFu GuangLong Biochem Major Business
Table 41. QuFu GuangLong Biochem Hyaluronic Acid (HA) for Medical Product and Services
Table 42. QuFu GuangLong Biochem Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Weifang Lide Bioengineering Basic Information, Manufacturing Base and Competitors
Table 44. Weifang Lide Bioengineering Major Business
Table 45. Weifang Lide Bioengineering Hyaluronic Acid (HA) for Medical Product and Services
Table 46. Weifang Lide Bioengineering Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Jiangsu Haihua Biotech Basic Information, Manufacturing Base and Competitors
Table 48. Jiangsu Haihua Biotech Major Business
Table 49. Jiangsu Haihua Biotech Hyaluronic Acid (HA) for Medical Product and Services
Table 50. Jiangsu Haihua Biotech Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Qufu Liyang Biochem Industrial Basic Information, Manufacturing Base and Competitors
Table 52. Qufu Liyang Biochem Industrial Major Business
Table 53. Qufu Liyang Biochem Industrial Hyaluronic Acid (HA) for Medical Product and Services
Table 54. Qufu Liyang Biochem Industrial Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. HAOHAI BIO-MED Basic Information, Manufacturing Base and Competitors
Table 56. HAOHAI BIO-MED Major Business
Table 57. HAOHAI BIO-MED Hyaluronic Acid (HA) for Medical Product and Services
Table 58. HAOHAI BIO-MED Hyaluronic Acid (HA) for Medical Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Hyaluronic Acid (HA) for Medical Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Hyaluronic Acid (HA) for Medical Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Hyaluronic Acid (HA) for Medical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Hyaluronic Acid (HA) for Medical Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Hyaluronic Acid (HA) for Medical Production Site of Key Manufacturer
Table 64. Hyaluronic Acid (HA) for Medical New Entrant and Capacity Expansion Plans
Table 65. Hyaluronic Acid (HA) for Medical Mergers & Acquisitions in the Past Five Years
Table 66. Global Hyaluronic Acid (HA) for Medical Sales by Region (2017-2022) & (K Units)
Table 67. Global Hyaluronic Acid (HA) for Medical Sales by Region (2023-2028) & (K Units)
Table 68. Global Hyaluronic Acid (HA) for Medical Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Hyaluronic Acid (HA) for Medical Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Hyaluronic Acid (HA) for Medical Sales by Type (2017-2022) & (K Units)
Table 71. Global Hyaluronic Acid (HA) for Medical Sales by Type (2023-2028) & (K Units)
Table 72. Global Hyaluronic Acid (HA) for Medical Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Hyaluronic Acid (HA) for Medical Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Hyaluronic Acid (HA) for Medical Price by Type (2017-2022) & (USD/Unit)
Table 75. Global Hyaluronic Acid (HA) for Medical Price by Type (2023-2028) & (USD/Unit)
Table 76. Global Hyaluronic Acid (HA) for Medical Sales by Application (2017-2022) & (K Units)
Table 77. Global Hyaluronic Acid (HA) for Medical Sales by Application (2023-2028) & (K Units)
Table 78. Global Hyaluronic Acid (HA) for Medical Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Hyaluronic Acid (HA) for Medical Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Hyaluronic Acid (HA) for Medical Price by Application (2017-2022) & (USD/Unit)
Table 81. Global Hyaluronic Acid (HA) for Medical Price by Application (2023-2028) & (USD/Unit)
Table 82. North America Hyaluronic Acid (HA) for Medical Sales by Country (2017-2022) & (K Units)
Table 83. North America Hyaluronic Acid (HA) for Medical Sales by Country (2023-2028) & (K Units)
Table 84. North America Hyaluronic Acid (HA) for Medical Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Hyaluronic Acid (HA) for Medical Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Hyaluronic Acid (HA) for Medical Sales by Type (2017-2022) & (K Units)
Table 87. North America Hyaluronic Acid (HA) for Medical Sales by Type (2023-2028) & (K Units)
Table 88. North America Hyaluronic Acid (HA) for Medical Sales by Application (2017-2022) & (K Units)
Table 89. North America Hyaluronic Acid (HA) for Medical Sales by Application (2023-2028) & (K Units)
Table 90. Europe Hyaluronic Acid (HA) for Medical Sales by Country (2017-2022) & (K Units)
Table 91. Europe Hyaluronic Acid (HA) for Medical Sales by Country (2023-2028) & (K Units)
Table 92. Europe Hyaluronic Acid (HA) for Medical Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Hyaluronic Acid (HA) for Medical Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Hyaluronic Acid (HA) for Medical Sales by Type (2017-2022) & (K Units)
Table 95. Europe Hyaluronic Acid (HA) for Medical Sales by Type (2023-2028) & (K Units)
Table 96. Europe Hyaluronic Acid (HA) for Medical Sales by Application (2017-2022) & (K Units)
Table 97. Europe Hyaluronic Acid (HA) for Medical Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Hyaluronic Acid (HA) for Medical Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Hyaluronic Acid (HA) for Medical Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales by Application (2023-2028) & (K Units)
Table 106. South America Hyaluronic Acid (HA) for Medical Sales by Country (2017-2022) & (K Units)
Table 107. South America Hyaluronic Acid (HA) for Medical Sales by Country (2023-2028) & (K Units)
Table 108. South America Hyaluronic Acid (HA) for Medical Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Hyaluronic Acid (HA) for Medical Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Hyaluronic Acid (HA) for Medical Sales by Type (2017-2022) & (K Units)
Table 111. South America Hyaluronic Acid (HA) for Medical Sales by Type (2023-2028) & (K Units)
Table 112. South America Hyaluronic Acid (HA) for Medical Sales by Application (2017-2022) & (K Units)
Table 113. South America Hyaluronic Acid (HA) for Medical Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Hyaluronic Acid (HA) for Medical Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Hyaluronic Acid (HA) for Medical Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales by Application (2023-2028) & (K Units)
Table 122. Hyaluronic Acid (HA) for Medical Raw Material
Table 123. Key Manufacturers of Hyaluronic Acid (HA) for Medical Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Hyaluronic Acid (HA) for Medical Typical Distributors
Table 127. Hyaluronic Acid (HA) for Medical Typical Customers
List of Figures
Figure 1. Hyaluronic Acid (HA) for Medical Picture
Figure 2. Global Hyaluronic Acid (HA) for Medical Revenue Market Share by Type in 2021
Figure 3. Injection
Figure 4. Patch
Figure 5. Global Hyaluronic Acid (HA) for Medical Revenue Market Share by Application in 2021
Figure 6. Medical Hygiene
Figure 7. Plastic Surgery
Figure 8. Health Products
Figure 9. Other
Figure 10. Global Hyaluronic Acid (HA) for Medical Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Hyaluronic Acid (HA) for Medical Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Hyaluronic Acid (HA) for Medical Sales (2017-2028) & (K Units)
Figure 13. Global Hyaluronic Acid (HA) for Medical Price (2017-2028) & (USD/Unit)
Figure 14. Global Hyaluronic Acid (HA) for Medical Production Capacity (2017-2028) & (K Units)
Figure 15. Global Hyaluronic Acid (HA) for Medical Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Hyaluronic Acid (HA) for Medical Market Drivers
Figure 17. Hyaluronic Acid (HA) for Medical Market Restraints
Figure 18. Hyaluronic Acid (HA) for Medical Market Trends
Figure 19. Global Hyaluronic Acid (HA) for Medical Sales Market Share by Manufacturer in 2021
Figure 20. Global Hyaluronic Acid (HA) for Medical Revenue Market Share by Manufacturer in 2021
Figure 21. Hyaluronic Acid (HA) for Medical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Hyaluronic Acid (HA) for Medical Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Hyaluronic Acid (HA) for Medical Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Hyaluronic Acid (HA) for Medical Sales Market Share by Region (2017-2028)
Figure 25. Global Hyaluronic Acid (HA) for Medical Revenue Market Share by Region (2017-2028)
Figure 26. North America Hyaluronic Acid (HA) for Medical Revenue (2017-2028) & (USD Million)
Figure 27. Europe Hyaluronic Acid (HA) for Medical Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Hyaluronic Acid (HA) for Medical Revenue (2017-2028) & (USD Million)
Figure 29. South America Hyaluronic Acid (HA) for Medical Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Hyaluronic Acid (HA) for Medical Revenue (2017-2028) & (USD Million)
Figure 31. Global Hyaluronic Acid (HA) for Medical Sales Market Share by Type (2017-2028)
Figure 32. Global Hyaluronic Acid (HA) for Medical Revenue Market Share by Type (2017-2028)
Figure 33. Global Hyaluronic Acid (HA) for Medical Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Hyaluronic Acid (HA) for Medical Sales Market Share by Application (2017-2028)
Figure 35. Global Hyaluronic Acid (HA) for Medical Revenue Market Share by Application (2017-2028)
Figure 36. Global Hyaluronic Acid (HA) for Medical Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Hyaluronic Acid (HA) for Medical Sales Market Share by Type (2017-2028)
Figure 38. North America Hyaluronic Acid (HA) for Medical Sales Market Share by Application (2017-2028)
Figure 39. North America Hyaluronic Acid (HA) for Medical Sales Market Share by Country (2017-2028)
Figure 40. North America Hyaluronic Acid (HA) for Medical Revenue Market Share by Country (2017-2028)
Figure 41. United States Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Hyaluronic Acid (HA) for Medical Sales Market Share by Type (2017-2028)
Figure 45. Europe Hyaluronic Acid (HA) for Medical Sales Market Share by Application (2017-2028)
Figure 46. Europe Hyaluronic Acid (HA) for Medical Sales Market Share by Country (2017-2028)
Figure 47. Europe Hyaluronic Acid (HA) for Medical Revenue Market Share by Country (2017-2028)
Figure 48. Germany Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Hyaluronic Acid (HA) for Medical Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Hyaluronic Acid (HA) for Medical Revenue Market Share by Region (2017-2028)
Figure 57. China Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Hyaluronic Acid (HA) for Medical Sales Market Share by Type (2017-2028)
Figure 64. South America Hyaluronic Acid (HA) for Medical Sales Market Share by Application (2017-2028)
Figure 65. South America Hyaluronic Acid (HA) for Medical Sales Market Share by Country (2017-2028)
Figure 66. South America Hyaluronic Acid (HA) for Medical Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Hyaluronic Acid (HA) for Medical Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Hyaluronic Acid (HA) for Medical Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Hyaluronic Acid (HA) for Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Hyaluronic Acid (HA) for Medical in 2021
Figure 78. Manufacturing Process Analysis of Hyaluronic Acid (HA) for Medical
Figure 79. Hyaluronic Acid (HA) for Medical Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source